Contact Us

Focus

CARsgen's Allogeneic CD38 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial

SHANGHAI,Jan. 20,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors

Focus

Jan 21, 2025

Infobip Research Unveils Opportunities for Brands to Engage Customers with Rich Communication Services (RCS) across APAC

Indonesia,Malaysia,Philippines,India and Singapore record massive smartphone user bases KUALA LUMPUR,Jan. 20,2025-- Global cloud communication platform,Infobip has unveiled a new report titled \'RCS:

Focus

Jan 21, 2025

DAHON Unveils Groundbreaking D-VELO Speed Technology at CABDA 2025 in New York

NEW YORK,Jan. 21,2025-- On January 15,theCABDA EAST Expo kicked off at the Meadowlands Exposition Center in New York,where DAHON unveiled its new "D-VELO" technology,captivating the interest

Focus

Jan 21, 2025

Ascentium Expands Strategic Footprint in the Middle East through Acquisition of Virtuzone

SINGAPORE,Jan. 21,2025-- Ascentium,a leading global business services platform headquartered in Singapore and backed by Hillhouse Investment,has announced the acquisition of Virtuzone,the UAE\'s lead

Focus

Jan 21, 2025

YolTech Therapeutics to Initiate a Clinical Trial for YOLT-204, a First-in-Class Bone Marrow-Targeted In Vivo Gene Editing Therapy for β-Thalassemia

SHANGHAI,Jan. 21,2025--YolTech Therapeutics,a clinical-stage gene editing company dedicated to delivering lifelong cures,announced the initiation of a clinical trial for YOLT-204,an investigational th

Focus

Jan 21, 2025

Budget Direct Insurance Launches Commercial Vehicle Insurance in Singapore

SINGAPORE,Jan. 21,2025--Budget Direct Insurance,a leading direct-to-consumer digital insurer,has announced the launch of its Commercial Vehicle Insurance product,designed to meet the needs of business

Focus

Jan 21, 2025
1 ... 102 103 104 105 106 107 108 ... 118